Correlagen Diagnostics, Inc. Sustainability Profile
Correlagen Diagnostics, Inc., headquartered in the United States, is a pioneering leader in the field of genetic testing and diagnostics. Founded in 2005, the company has established itself as a key player in the biotechnology industry, focusing on innovative solutions for genetic disorders and personalised medicine. With a strong emphasis on advanced genomic technologies, Correlagen offers a range of unique services, including comprehensive genetic testing and analysis, which are designed to provide precise insights for clinicians and patients alike. The company’s commitment to quality and accuracy has earned it a notable position in the market, recognised for its contributions to improving patient outcomes through tailored diagnostic solutions. As Correlagen continues to expand its operational reach, it remains dedicated to advancing the understanding of genetic conditions, solidifying its reputation as a trusted partner in the healthcare community.
DitchCarbon Score
How does Correlagen Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Correlagen Diagnostics, Inc.'s score of 44 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Correlagen Diagnostics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Labcorp Holdings Inc., which may influence its climate commitments and reporting practices. As part of its corporate family relationship, Correlagen's climate initiatives and targets are likely aligned with those of Labcorp Holdings Inc. However, specific reduction targets or achievements have not been disclosed for Correlagen. The absence of documented reduction initiatives or commitments suggests that the company may still be in the process of establishing its own climate strategy. Labcorp Holdings Inc. has been active in setting science-based targets and participating in various climate initiatives, which may cascade down to Correlagen. Nonetheless, without explicit data or commitments from Correlagen itself, it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 69,115,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 178,899,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Correlagen Diagnostics, Inc.'s Industry?
How Carbon Intensive is Correlagen Diagnostics, Inc.'s Location?
Correlagen Diagnostics, Inc.'s Scope 3 Categories Breakdown
Correlagen Diagnostics, Inc.'s Scope 3 emissions, which decreased by 4% last year and increased by approximately 10% since 2020, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 76% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Top Scope 3 Categories
Correlagen Diagnostics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Correlagen Diagnostics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
